Literature DB >> 3741455

Non-linear pharmacokinetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracil.

E A de Bruijn, L Remeyer, U R Tjaden, C Erkelens, L M de Brauw, C J van de Velde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3741455     DOI： 10.1016/0006-2952(86)90041-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-deoxyuridine.

Authors:  H J Keizer; E A De Bruijn; U R Tjaden; E De Clercq
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

2.  Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.

Authors:  S A Van Der Heyden; M S Highley; E A De Bruijn; U R Tjaden; H J Reeuwijk; H Van Slooten; A T Van Oosterom; R A Maes
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of breast cancer.

Authors:  V J Wiebe; C C Benz; M W DeGregorio
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

4.  Plasma 5-fluorouracil and alpha-fluoro-beta-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil.

Authors:  L Thiberville; P Compagnon; N Moore; G Bastian; M O Richard; M F Hellot; C Vincent; M M Kannass; S Dominique; C Thuillez
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Pharmacokinetic analysis of doxifluridine and its metabolites, 5-fluorouracil and 5-fluorouridine, after oral administration in beagle dogs.

Authors:  In-Hwan Baek; Byung-Yo Lee; Min-Soo Kim; Kwang-Il Kwon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-07       Impact factor: 2.441

6.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.

Authors:  G J Peters; J Lankelma; R M Kok; P Noordhuis; C J van Groeningen; C L van der Wilt; S Meyer; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through system.

Authors:  E C Spoelstra; H M Pinedo; H Dekker; G J Peters; J Lankelma
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Fluorouracil catabolism in the combination treatment of cyclophosphamide, methotrexate and fluorouracil.

Authors:  E A De Bruijn; S A Van der Heyden; E E Gheuens; R A Maes
Journal:  Jpn J Cancer Res       Date:  1992-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.